Cargando…

ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ

OBJECTIVE(S): The present study’s objective was to investigate the association between angiopoietin-like 4 (ANGPTL4) levels and the prognosis of Atrial fibrillation (AF), the causative effect in angiotensin II- (Ang II) induced AF, and its underlying mechanisms. MATERIALS AND METHODS: Baseline serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xi, Zhang, Xiaogang, Gu, Wei, Zhao, Hanjun, Hao, Shuwen, Ning, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083826/ https://www.ncbi.nlm.nih.gov/pubmed/37051105 http://dx.doi.org/10.22038/IJBMS.2023.69196.15077

Ejemplares similares

ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
por: Zhu, Xi, et al.
Publicado: (2021)

ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia
por: Liu, Lei, et al.
Publicado: (2017)

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
por: Wu, Yingbiao, et al.
Publicado: (2023)

Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway
por: Wang, Guoqiang, et al.
Publicado: (2021)

Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
por: Li, Jin, et al.
Publicado: (2020)

LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β1/Smad3/NF-κB pathway
por: Luo, Jun, et al.
Publicado: (2022)

Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues
por: Lee, Won Jai, et al.
Publicado: (2018)

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
por: Adhikary, T, et al.
Publicado: (2013)

PPARβ/δ recruits NCOR and regulates transcription reinitiation of ANGPTL4
por: Legrand, Nathalie, et al.
Publicado: (2019)

MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease
por: Huang, Jia, et al.
Publicado: (2014)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Loss of PPARγ expression by fibroblasts enhances dermal wound closure
por: Sha, Wei, et al.
Publicado: (2012)

Metformin promotes osteogenic differentiation and prevents hyperglycaemia-induced osteoporosis by suppressing PPARγ expression: Metformin prevents osteoporosis by suppressing PPARγ
por: Zheng, Lifeng, et al.
Publicado: (2023)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II
por: Sun, Li, et al.
Publicado: (2019)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

Multimechanistic Antifibrotic Effect of Biochanin A in Rats: Implications of Proinflammatory and Profibrogenic Mediators
por: Breikaa, Randa M., et al.
Publicado: (2013)

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
por: Hegde, Pushpa, et al.
Publicado: (2018)

CHD7 regulates bone-fat balance by suppressing PPAR-γ signaling
por: Liu, Caojie, et al.
Publicado: (2022)

Shockwaves Suppress Adipocyte Differentiation via Decrease in PPARγ
por: Cho, Wonkyoung, et al.
Publicado: (2020)

Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo
por: Khodayari, Nazli, et al.
Publicado: (2020)

Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells
por: Valentino, Gina, et al.
Publicado: (2019)

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway
por: La Paglia, Laura, et al.
Publicado: (2017)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
por: Hai, Zhen, et al.
Publicado: (2023)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis
por: Li, Xiao-Feng, et al.
Publicado: (2017)

PPARγ activation suppresses chondrocyte ferroptosis through mitophagy in osteoarthritis
por: Xue, Xiang, et al.
Publicado: (2023)

Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022)

Percutaneous Retrieval of Left Atrial Appendage Closure Devices in Patients With Atrial Fibrillation: A Case Report
por: Wang, Saihua, et al.
Publicado: (2022)

Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis
por: Zhang, Wei, et al.
Publicado: (2023)

Oral Squamous Cell Carcinoma-Derived ANGPTL3 Induces Cancer Associated Fibroblastic Phenotypes in Surrounding Fibroblasts
por: Kim, Jue Young, et al.
Publicado: (2022)

Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism
por: Hogan, Christopher M., et al.
Publicado: (2011)

Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator
por: Hamano, Yuki, et al.
Publicado: (2011)

Role of Vascular Smooth Muscle PPARγ in Regulating AT(1) Receptor Signaling and Angiotensin II-Dependent Hypertension
por: Carrillo-Sepulveda, Maria Alicia, et al.
Publicado: (2014)

Exercise attenuates angiotensinⅡ-induced muscle atrophy by targeting PPARγ/miR-29b
por: Liu, Qi, et al.
Publicado: (2022)

Do PPARγ Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?
por: Suzuki, Satoru, et al.
Publicado: (2008)

SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ
por: Khan, Danish, et al.
Publicado: (2021)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2thvm1e2tabl1ngn4mh9sqk96u